The Binding Site GmbH

At Binding Site we constantly strive to improve the tools available to laboratory professionals around the world for diagnosing and monitoring disease. Our origins date back to a group of researchers within the Medical School of Birmingham University who first started looking at innovative ways of producing antibodies in the early 1970's. With a desire to continue this early work but lacking the required government funding they founded a private company to take the research forward and utilise any potential commercial benefits. That company has evolved into The Binding Site and for over 25 years we have specialised in producing highly sensitive and highly specific antibodies used for the detection of certain cancers and other serious disorders.

We have built our business on the firm foundations of scientific evidence and the willingness and ability to respond to the requirements of researchers and clinicians alike. With our roots firmly planted in the clinical application of laboratory diagnostics we have never lost sight of the ultimate beneficiary of our products - the patient.